Cytogenetic Study Of Peripheral Blood Leukocytes In Patients With Uterine Mesenchymal Tumors

According to the World Health Organization, uterine tumours rank second in the structure of oncological morbidity in women. Epithelial tumours account for 95% of all genital tumours and only 5% are mesenchymal tumours. Malignant mesenchymal tumours include uterine sarcomas. Annually, 10 cases of uterine sarcomas are diagnosed in 1 million women worldwide. The problems of early diagnosis and screening of malignant uterine mesenchymal tumours (sarcomas) have not yet been solved. Due to the fact that this disease is rare and the treatment of uterine sarcomas remains a pressing problem.